avances de la lucha contra esta grave epidemia y al abandono de la vía intravenosa como for- . generalizada en todos los países (buprenorfina). Los opiáceos evaluados incluyeron buprenorfina intravenosa e intramuscular, petidina intramuscular, pentazocina intravenosa, fentanil transdérmico y morfina . de buprenorfina. Envase con 6 ampolletas o frascos ámpula con 1 ml. Intramuscular o intravenosa. Adultos: a mg/día, fraccionar dosis cada 6 horas.
|Published (Last):||18 October 2006|
|PDF File Size:||5.87 Mb|
|ePub File Size:||1.96 Mb|
|Price:||Free* [*Free Regsitration Required]|
N Engl J Med.
Emo United States U. Neurotransmitters, drugs and brain function. A trial of relapse prevention with severely dependent male problem drinkers.
Escalera analgésica en pediatría
The measurements were registered 30 minutes after beginning the inhalatory anaesthesia and before opioid administration M1 ; 15 minutes after buprenorphine administration M2. Rev Esp Salud Publica. A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids. Regulations of opioid dependence by opioid receptor types. Am J Public Health. Diagnostic and statistical manual of mental disorders: Ann Med Interne Paris.
A comparison of buprenorphine treatment in clinic and primary care settings: Treatment of substance-related disorders.
A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. Woodley M, Whelan A. Effective medical treatment of opiate addiction. J Consult Clin Psychol. International statistical classification of diseases and related health problems.
American Psychiatric Publishing; Psychopharmacology of reward and drugs of abuse. How to cite this article. Serial measurements were carried out in minute intervals after the administration of buprenorphine up to 45 minutes M3, M4 and M5.
Marlatt GA, Barrett K. Opiate maintenance therapy with LAAM. Maintenance treatment of opiate addicts in Germany with medications containing codeine – results of a follow-up study. Epidemiological trends in drug abuse series online [cited June].
World Health Organization; Apenas 12 alunos de uma amostra com mais de The impact of harm-reduction-based methadone treatment on mortality among heroin users. Galanter M, Kleber HD.
Services on Demand Journal.
Buprenorphine versus methadone maintenance: Psychiatr Clin North Am. The results allow us to conclude that buprenorphine IV or IM did not produce alterations on the cardiovascular parameters that could provide any significant clinics effects in dogs anesthetized with desflurane. Med Clin North Am. Clonidine is not a useful adjunct to methadone gradual detoxification in opioid addiction.
Efficacy of relapse prevention: American Psychiatry Press; Eur J Clin Invest. A propos du role des traitements de substitution. Andrade AG, Nicastri S. Process and outcome changes with relapse prevention versus step aftercare programs for substance abusers.
The aim of this study was to evaluate comparatively the effects of buprenorphine administered intramuscularly or intravenously on cardiovascular variables in dogs anesthetized with desflurane. Basic neurobiology of opiate addiction.
There was a problem providing the content you requested
Experiences with an outpatient relapse program community reinforcement approach combined with naltrexone in the treatment of opioid-dependence: Retention rate and illicit opioid use during methadone maintenance interventions: Medical care of doctors. Differentiation in the Amsterdam methadone dispensing circuit: Evaluation of the buprenorphine administered by intravenously or intramuscularly in dogs anesthetized with desflurane.
Tratamiento de los trastornos por abuso de sustancias. A pilot study of memantine effects on protracted withdrawal syndrome of anhedonia in heroin addicts. Galanter M, Kleber HD, editors. Essentials of clinical psychopharmacology. Carlini EA, et al. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.
Opiate addiction and the locus coeruleus. Controlled, randomized trial in maintenance treatment of intravenous buprenorphine dependence with naltrexone, methadone or buprenorphine: